Pharma Reviews: India Rejects China's 1.3 Billion Dollar Proposal to Buy Gland Pharma Amid Doklam Row

The government stalled the proposal of China's Shanghai Fosun Pharmaceutical to buy an 86 per cent stake in Hyderabad-based Gland Pharma.
Read more: India Rejects China's 1.3 Billion Dollar Proposal to Buy Gland Pharma Amid Doklam Row